Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.

International journal of cancer·2026
Same author

Cigarette smoking drives earlier development of pancreatic adenocarcinoma among carriers of hereditary pancreatic cancer susceptibility genes.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same author

A Biomarker Panel for the Detection of Pancreatic Cancer.

Cancers·2026
Same author

Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups.

BMC cancer·2026
Same author

Reply.

Gastroenterology·2026
Same author

DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Real-Time Study.

Gastroenterology·2026

Related Experiment Video

Updated: Jun 5, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

New developments in pancreatic cancer.

Julia B Greer1, Randall E Brand

  • 1Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Medical Arts Building, 3708 Fifth Avenue, Fourth Floor, Pittsburgh, PA 15213, USA. greerjb@upmc.edu

Current Gastroenterology Reports
|January 25, 2011
PubMed
Summary

Understanding pancreatic cancer risk involves genetics and lifestyle. Key factors include blood group, healthy habits like diet and exercise, and avoiding smoking, which can improve prognosis.

More Related Videos

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Related Experiment Videos

Last Updated: Jun 5, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Area of Science:

  • Oncology
  • Genetics
  • Epidemiology

Background:

  • Pancreatic adenocarcinoma has a poor prognosis, often diagnosed at advanced stages.
  • Recent research enhances understanding of pancreatic cancer causes and prognostication.
  • Molecular analysis highlights the importance of studying carcinogenic pathways over single gene mutations.

Purpose of the Study:

  • To review current knowledge on pancreatic cancer etiology and risk factors.
  • To identify validated and novel risk factors for pancreatic cancer.
  • To explore prognostic indicators for guiding treatment decisions.

Main Methods:

  • Review of recent research on pancreatic cancer etiology and risk.
  • Analysis of molecular pathways in pancreatic carcinogenesis.
  • Identification of lifestyle and genetic risk factors.
  • Evaluation of prognostic markers such as CA 19-9, diabetes, and gene signatures.

Main Results:

  • Established risk factors (family history, BMI, smoking) were validated.
  • Novel risk factors, including ABO blood group alleles, were identified.
  • Combinations of healthy habits (no smoking, Mediterranean diet, physical activity) may reduce risk.
  • CA 19-9 levels, diabetes mellitus, and a six-gene signature are critical for survival prediction.

Conclusions:

  • Pancreatic cancer risk is influenced by a combination of genetic predispositions and lifestyle choices.
  • Prognostic markers can provide valuable information for tailoring treatment strategies.
  • Further research into molecular pathways and risk factor interactions is crucial for improving outcomes.